In addition, we investigated DR6 expression in the developing hippocampus of patients with Down syndrome (DS) prior to establishment of AD neurodegeneration and in DS patients with AD pathology compared with age-matched control, and in hippocampal specimens obtained from patients with sporadic AD with severe, endstage pathology. This evidence concerns the gene TNFRSF21 and Alzheimer disease.